FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to compounds of formula 
(I), formula 
(XI), formula 
(CI) and formula 
(Ml). The values R1,R2,R3, X, L, A, M, Q, n, i, p, w are presented in the patent claims 1,4,10,16; the invention also refers to method for preparing such compounds and using them in treating inflammatory diseases.
EFFECT: preparing new compounds for treating inflammatory diseases.
22 cl, 1 tbl, 45 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS | 2018 |
|
RU2797822C2 |
| TRICYCLIC CONDENSED DERIVATIVES OF PYRIDIN-2-ONE AND USE THEREOF AS BRD4 INHIBITORS | 2016 |
|
RU2734959C2 |
| BICYCLIC COMPOUNDS AS PD1/PD-L1 INTERACTION/ACTIVATION INHIBITORS | 2019 |
|
RU2777980C2 |
| NOVEL HETEROCYCLIC COMPOUNDS AS BRD4 INHIBITORS | 2016 |
|
RU2721120C2 |
| RAD51 INHIBITORS | 2018 |
|
RU2795882C2 |
| JAK-INHIBITING TRIAZOLOPYRIDINE COMPOUNDS AND METHODS | 2009 |
|
RU2560153C2 |
| NON-ANILINE DERIVATIVES OF ISOTHIAZOLE-3(2H)-OH-1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS | 2006 |
|
RU2415135C2 |
| BICYCLIC AMINE DERIVATIVES AS TYROSINE KINASE INHIBITORS | 2007 |
|
RU2465275C2 |
| HETEROCYCLIC COMPOUNDS | 2005 |
|
RU2390522C2 |
| TRIAZOLOPYRIDINE JAK INHIBITOR COMPOUNDS AND METHODS | 2009 |
|
RU2561104C2 |
